A Retrospective,cohort study assessing cardiovascular events risks leading to hospitalisation in patients with hypertension recieving monotherapy with Nebivolol,Atenolol or Metoprolol

Trial Profile

A Retrospective,cohort study assessing cardiovascular events risks leading to hospitalisation in patients with hypertension recieving monotherapy with Nebivolol,Atenolol or Metoprolol

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2016

At a glance

  • Drugs Nebivolol (Primary) ; Atenolol; Metoprolol
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Dec 2016 New trial record
    • 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association
    • 12 Nov 2016 According to Allergan media release, data will be presented at the American Heart Association (AHA) Annual Scientific Meeting 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top